-
May 31: The Week in Cancer News
A study finds that oral cancer medication costs for patients covered by Medicare Part D have increased, and the U.S. Food and Drug Administration approves a new targeted therapy for advanced breast cancer.
by Kate Yandell
-
May 24: The Week in Cancer News
Unequal access to care appears to be responsible for the elevated mortality rate from prostate cancer in black men, and women with a history of cancer who identify as lesbian or bisexual have reduced access to care.
by Kate Yandell
-
May 17: The Week in Cancer News
A study indicates that the Affordable Care Act decreased the proportion of people with a history of cancer who are uninsured, and access to appropriate targeted therapies may be lacking for some patients.
by Kate Yandell
-
When a Top-Ranked Cancer Center Comes to a Hospital Near You
Research shows prominent cancer hospitals have different surgical outcomes than their affiliates.
by Marci A. Landsmann
-
May 10: The Week in Cancer News
The spread of measles raises concerns among some cancer patients, and a treatment for early-stage HER2-positive breast cancer is approved by the U.S. Food and Drug Administration.
by Kate Yandell and Bradley Jones
-
Putting Chemotherapy Side Effects on Ice
A small study shows that keeping ice chips in the mouth during oxaliplatin chemotherapy may prevent cold sensitivity, a common oral side effect.
by Anna Azvolinsky
-
The Week in Cancer News: May 3
Prospective CRISPR application targets cancer directly, HER2 testing accessibility poor in many countries.
by Bradley Jones
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona